LYTIR

Company · BDX

Becton, Dickinson and Company

Name as listed on its exchange; filed with the SEC as BECTON DICKINSON & CO.

Nasdaq's symbol directory lists BDX on the New York Stock Exchange as “Becton, Dickinson and Company Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 12 occasions ($2.0M); 11 planned-sale notices; 2 filings by holders of 5% or more; 3 congressional trade disclosures; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.0M in total.Apr: Insider sales $11KMay: Insider sales $11KJun: Insider sales $743KJul: Insider sales $12KAug: Insider sales $1.2MSep: Insider sales $14KOct: Insider sales $15KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Polen Thomas E Jr, Chairman, CEO and President sold on 2 days all under a 10b5-1 plan latest Aug 13, 2026 sold $1.2M
  2. Goette Roland, EVP and President, EMEA sold on 1 day latest Aug 11, 2026 sold $441K
  3. Garrison Michael David, EVP & Pres Med.Essntl&BioPharm sold on 2 days all under a 10b5-1 plan latest Jun 24, 2026 sold $327K
  4. Feld Michael, EVP, Chief Revenue Officer sold on 7 days all under a 10b5-1 plan latest Oct 26, 2026 sold $106K
Every trade (12)
  1. SELLFeld Michael, EVP, Chief Revenue Officer sold Oct 26, 2026 76 shares 10b5-1 plan (scheduled) filing $15K
  2. SELLFeld Michael, EVP, Chief Revenue Officer sold Sep 28, 2026 76 shares 10b5-1 plan (scheduled) filing $14K
  3. SELLFeld Michael, EVP, Chief Revenue Officer sold Aug 26, 2026 165 shares 10b5-1 plan (scheduled) filing $31K
  4. SELLPolen Thomas E Jr, Chairman, CEO and President sold Aug 13, 2026 4,152 shares 10b5-1 plan (scheduled) filing $768K
  5. SELLGoette Roland, EVP and President, EMEA sold Aug 11, 2026 2,438 shares filing $441K
  6. SELLFeld Michael, EVP, Chief Revenue Officer sold Jul 27, 2026 75 shares 10b5-1 plan (scheduled) filing $12K
  7. SELLFeld Michael, EVP, Chief Revenue Officer sold Jun 26, 2026 75 shares 10b5-1 plan (scheduled) filing $11K
  8. SELLGarrison Michael David, EVP & Pres Med.Essntl&BioPharm sold Jun 24, 2026 1,100 shares 10b5-1 plan (scheduled) filing $160K
  9. SELLGarrison Michael David, EVP & Pres Med.Essntl&BioPharm sold Jun 10, 2026 1,100 shares 10b5-1 plan (scheduled) filing $167K
  10. SELLPolen Thomas E Jr, Chairman, CEO and President sold Jun 1, 2026 2,764 shares 10b5-1 plan (scheduled) filing $405K
  11. SELLFeld Michael, EVP, Chief Revenue Officer sold May 26, 2026 75 shares 10b5-1 plan (scheduled) filing $11K
  12. SELLFeld Michael, EVP, Chief Revenue Officer sold Apr 27, 2026 74 shares 10b5-1 plan (scheduled) filing $11K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. THOMAS POLEN filed Nov 5, 2026 Director 2,993 shares planned sale date 11/05/2026 filing $626K
  2. MICHAEL FELD filed Oct 26, 2026 Officer 76 shares planned sale date 10/26/2026 filing $15K
  3. MICHAEL FELD filed Sep 28, 2026 Officer 76 shares planned sale date 09/28/2026 filing $14K
  4. MICHAEL FELD filed Aug 26, 2026 Officer 165 shares planned sale date 08/26/2026 filing $31K
  5. RICHARD BYRD filed Aug 20, 2026 Former Officer 1,330 shares planned sale date 08/20/2026 filing $250K
  6. THOMAS POLEN filed Aug 13, 2026 Director 4,152 shares planned sale date 08/13/2026 filing $762K
  7. Roland Goette filed Aug 11, 2026 Officer 2,438 shares planned sale date 08/11/2026 filing $441K
  8. SHANA NEAL filed Aug 3, 2026 Officer 1,500 shares planned sale date 08/03/2026 filing $248K
  9. MICHAEL FELD filed Jul 27, 2026 Officer 75 shares planned sale date 07/27/2026 filing $12K
  10. MICHAEL FELD filed Jun 26, 2026 Officer 75 shares planned sale date 06/26/2026 filing $11K
  11. MICHAEL GARRISON filed Jun 24, 2026 Officer 1,100 shares planned sale date 06/24/2026 filing $158K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. STATE STREET CORPORATION filed Aug 7, 2026 Schedule 13G passive 15,014,710 shares filing 5.4%
  2. First Eagle Investment Management, LLC filed Aug 6, 2026 Schedule 13G passive 14,138,027 shares filing 5.1%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Thomas H. Kean (R-NJ07): Sale May 21, 2026 reported Jun 18, 2026 one of 4 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  3. Kevin Hern (R-OK01): Sale Mar 17, 2026 reported Apr 3, 2026 one of 16 trades the member reported that day House Stocks (including ADRs) owner: joint $15,001 - $50,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Results of operations and financial condition filing Aug 6, 2026
  3. Departure or appointment of directors or officers; Regulation FD disclosure filing Jul 22, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.